LogicMark Inc. Transitions to OTC Markets Following Nasdaq Delisting Due to Bid Price Non-Compliance

Reuters
02 Jun
LogicMark Inc. Transitions to OTC Markets Following Nasdaq Delisting Due to Bid Price Non-Compliance

LogicMark, Inc. has announced that its common stock will begin trading on the over-the-counter markets effective June 2, 2025, following Nasdaq's decision to delist the company's stock due to non-compliance with the $1.00 minimum bid price requirement. The company, a provider of personal emergency response systems and health communication devices, remains committed to advancing its growth initiatives and evaluating various market tiers within the OTC Markets. LogicMark has also expressed the possibility of returning to a national exchange in the future.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LogicMark Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-049700), on June 02, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10